Search research articles
Contact Us
Filters
Showing results (821-830 of 948) with videos related to
Page
of 95
Sort By:
Kidney International
|
July 29, 2017
Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland
Vicky Brocklebank, Sally Johnson, Thomas P Sheerin, et al.
Trials
|
January 18, 2023
Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial
Guillaume Martel, Tori Lenet, Christopher Wherrett, et al.
Science Translational Medicine
|
April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Joseph H Choe, Payal B Watchmaker, Milos S Simic, et al.
Brain : a Journal of Neurology
|
January 28, 2025
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine
Sarasa Tohyama, Michael Datko, Ludovica Brusaferri, et al.
The Journal of Clinical Investigation
|
August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Sabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Journal of Clinical Investigation
|
June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Sabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Lancet. Gastroenterology & Hepatology
|
December 12, 2024
Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trial
Guillaume Martel, François Martin Carrier, Christopher Wherrett, et al.
Human Mutation
|
December 2, 2017
Inactivation of AMMECR1 is associated with growth, bone, and heart alterations
Mariana Moysés-Oliveira, Giuliana Giannuzzi, Richard J Fish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
N W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003
N W Clarke, A Ali, F C Ingleby, et al.
Page
of 95
Search research articles
Search
Showing results (821-830 of 948) with videos related to
Sort By:
Page
of 95
Kidney International
|
July 29, 2017
Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland
Vicky Brocklebank, Sally Johnson, Thomas P Sheerin, et al.
Trials
|
January 18, 2023
Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial
Guillaume Martel, Tori Lenet, Christopher Wherrett, et al.
Science Translational Medicine
|
April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Joseph H Choe, Payal B Watchmaker, Milos S Simic, et al.
Brain : a Journal of Neurology
|
January 28, 2025
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine
Sarasa Tohyama, Michael Datko, Ludovica Brusaferri, et al.
The Journal of Clinical Investigation
|
August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Sabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Journal of Clinical Investigation
|
June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Sabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
The Lancet. Gastroenterology & Hepatology
|
December 12, 2024
Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trial
Guillaume Martel, François Martin Carrier, Christopher Wherrett, et al.
Human Mutation
|
December 2, 2017
Inactivation of AMMECR1 is associated with growth, bone, and heart alterations
Mariana Moysés-Oliveira, Giuliana Giannuzzi, Richard J Fish, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
N W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003
N W Clarke, A Ali, F C Ingleby, et al.
Page
of 95